9/10/2013 9:15:16 AM
SAN DIEGO, Sept. 9, 2013 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals (Nasdaq:CNAT), a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease, today announced financial results for the quarter ended June 30, 2013.
Help employers find you! Check out all the jobs and post your resume.
comments powered by